Trials / Terminated
TerminatedNCT02920177
Platelet-rich Plasma Versus Corticosteroid Injection for the Treatment of Femoroacetabular Impingement
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 4 (actual)
- Sponsor
- University of Michigan · Academic / Other
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the clinical response of intra-articular platelet rich plasma (PRP) versus corticosteroid injection in patients affected by femoroacetabular impingement (FAI).
Detailed description
This study will determine if PRP treatment of FAI improves (i) patient reported outcome scores and (ii) hip functional stability compared to standard corticosteroid treatment and if PRP treatment of FAI reduces (i) radiographic and (ii) biochemical markers of joint inflammation and cartilage degradation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | platelet-rich plasma injection | platelet-rich plasma injection |
| DRUG | Kenalog 10 MG/ML Injectable Suspension | 4 mL corticosteroid injection |
Timeline
- Start date
- 2016-08-01
- Primary completion
- 2018-08-10
- Completion
- 2018-08-10
- First posted
- 2016-09-30
- Last updated
- 2020-04-03
- Results posted
- 2020-04-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02920177. Inclusion in this directory is not an endorsement.